Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
American Journal of Hematology|November 2, 2012
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemiaFrancesco Maura, Carlo Visco, Erika Falisi, et al.
Blood Advances|June 12, 2023
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphomaDiego Villa, Aixiang Jiang, Carlo Visco, et al.
European Journal of Haematology|June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcomeDavide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.
Thrombosis and Haemostasis|April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2013
NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastasesGianpaolo Fogliatto, Laura Gianellini, Maria G Brasca, et al.
Leukemia & Lymphoma|February 5, 2015
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemiaAlessandra Tedeschi, Paola Picardi, Simone Ferrero, et al.
Cancers|February 15, 2022
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela StudyBeatrice Casadei, Lisa Argnani, Alessandro Broccoli, et al.
American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
British Journal of Cancer|September 27, 2017
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocationsCarlo Visco, Jinfen Wang, Maria Chiara Tisi, et al.
Pageof 17